Michelle Bloom in New York, New York

Home New York New York

Michelle Bloom has Cardiovascular Disease (cardiology) as her primary medical specialty. Their primary office is: 550 1st Ave in New York, New York. There is an additional office location, for a total of two, for Michelle Bloom that can be viewed further down.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-7300 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michelle E Bloom Office Phone and Directions

Michelle Bloom
New York University
550 1st Ave
New York, New York 10016
212-263-7300

Patient Ratings
Please rate your experience with Michelle Bloom below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-263-7300

Enter a starting address:

Healthcare Info for Michelle Bloom

Additional Medical Specialties Include:
ADVANCED HEART FAILURE AND TRANSPLANT CARDIOLOGY

Medical School: Sorry, her university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Michelle Bloom is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 21
PAC (PECOS ID)#: 0648458802
NPI #: 1952569873
NPI Created On: 05/28/2008
NPI Last Updated Listed as: 10/10/2023
Primary Taxonomy Code: 207RC0000X
License Number:
232791
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Routine ekg using at least 12 leads including interpretation and report
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 30 minutes per day
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, 30 minutes or less
Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,800

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 816087657

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $2,588

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 816097095

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $900

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 816097617

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $900

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 816102561

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 816136275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $2,250

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 816143379

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hyperkalemia

Name of Drug #1: Veltassa

Open Associated Drug #1: 53436-084-30

Payments Total: $1,343

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 829428603

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Speaker Expenses

Record ID:: 829445523

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30

Payments Total: $2,150

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Speaker Fee

Record ID:: 829479237

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30

Payments Total: $120

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Speaker Expenses

Record ID:: 829753787

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30

Additional Office Locations

1. Stony Brook Internists University Faculty Practice Corporation
301 E Main St
Bay Shore, NY 11706
Group Members: 364

Phone: 212-263-7300

Enter a starting address:

Cardiovascular Disease (cardiology) Professionals in New York

1.
John Dodson

16 Th St And 1st Ave
New-york, NY
New York University

2.
John Dodson

301 E 17th St
New-york, NY
New York University

3.
John Dodson

111 Broadway
New-york, NY
New York University

4.
John Dodson

240 E 38th St
New-york, NY
New York University

5.
John Dodson

530 1st Ave
New-york, NY
New York University

6.
John Dodson

550 1st Ave
New-york, NY
New York University

Providers in New York University

1.Jennifer Abate

240 E 38th St
New York Ny 10016-2708
New York University
Nurse Practitioner

2.Nabil Abazaid

111 Broadway
New York Ny 10006-1901
New York University
Emergency Medicine

3.Valentino Abballe

16 Th St And 1st Ave
New York Ny 10003-3804
New York University
Diagnostic Radiology

4.Valentino Abballe

301 E 17th St
New York Ny 10003-3804
New York University
Diagnostic Radiology

5.Valentino Abballe

111 Broadway
New York Ny 10006-1901
New York University
Diagnostic Radiology

6.Valentino Abballe

111 Broadway
New York Ny 10006-1995
New York University
Diagnostic Radiology

View all 4,291 members of New York University medical group